Fluorescein sodium–guided resection of cervical peripheral nerve sheath tumors in 3 dogs

Objective: To describe the intraoperative findings and outcomes of fluorescein sodium-guided resection of cervical peripheral nerve sheath tumors (PNSTs) in dogs, including in the re-operative setting. Animals: 3 client-owned dogs with cervical PNST. Two dogs underwent a second resection of progressive malignant PNST (MPNST) after subtotal resection and stereotactic radiation therapy performed elsewhere. One dog underwent primary resection of a previously untreated PNST identified as a schwannoma. Clinical Presentation: Affected dogs were between 10 and 11 years of age (weighing between 4.2 and 5.4 kg) and presented with cervical pain, hyperesthesia, or tetraparesis. Preoperative MRI revealed contrast-enhancing intradural extramedullary masses with extraforaminal extensions. Results: Fluorescein sodium (20 mg/kg) was administered IV after surgical exposure. Tumor tissue exhibited yellow discoloration under standard illumination in all dogs and bright fluorescence under 395-nm UV illumination in 2 dogs and, in the 2 re-operative cases, was visually distinct from the surrounding postoperative and radiation-induced fibrosis, which was grossly assessed as nondiseased and did not take up fluorescein. This contrast assisted dissection, and gross total resection was achieved in all dogs; nonfluorescent tissue was not biopsied. Histopathology confirmed MPNST in 2 dogs and schwannoma in 1 dog. Fluorescein-related adverse events were not observed. Both MPNST cases developed remote or metastatic disease within 4 months (1 euthanized); the schwannoma case was recurrence-free at 3 months. Clinical Relevance: Fluorescein sodium-guided resection of canine cervical PNSTs is feasible with widely available equipment and may aid intraoperative identification of tumor tissue in both primary and re-operative settings, suggesting a lower equipment barrier than commonly assumed. Because nonfluorescent tissue was not sampled, fluorescein should be an adjunct to, not a substitute for, surgical judgment.

Authors

Institutions

Publication Details

Journal
Journal of the American Veterinary Medical Association
Published
2026-11-13
DOI
https://doi.org/10.2460/javma.26.08.0620
Primary Topic
Veterinary Oncology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Fluorescein sodium–guided resection of cervical peripheral nerve sheath tumors in 3 dogs

Daisuke Hasegawa, Joohyun Jung, Narae Jeong
2 links
Journal of the American Veterinary Medical Association
Veterinary Oncology Research
article

Fluorescein sodium–guided resection of cervical peripheral nerve sheath tumors in 3 dogs

Daisuke Hasegawa, Joohyun Jung, Narae Jeong
article en

Abstract

Objective: To describe the intraoperative findings and outcomes of fluorescein sodium-guided resection of cervical peripheral nerve sheath tumors (PNSTs) in dogs, including in the re-operative setting. Animals: 3 client-owned dogs with cervical PNST. Two dogs underwent a second resection of progressive malignant PNST (MPNST) after subtotal resection and stereotactic radiation therapy performed elsewhere. One dog underwent primary resection of a previously untreated PNST identified as a schwannoma. Clinical Presentation: Affected dogs were between 10 and 11 years of age (weighing between 4.2 and 5.4 kg) and presented with cervical pain, hyperesthesia, or tetraparesis. Preoperative MRI revealed contrast-enhancing intradural extramedullary masses with extraforaminal extensions. Results: Fluorescein sodium (20 mg/kg) was administered IV after surgical exposure. Tumor tissue exhibited yellow discoloration under standard illumination in all dogs and bright fluorescence under 395-nm UV illumination in 2 dogs and, in the 2 re-operative cases, was visually distinct from the surrounding postoperative and radiation-induced fibrosis, which was grossly assessed as nondiseased and did not take up fluorescein. This contrast assisted dissection, and gross total resection was achieved in all dogs; nonfluorescent tissue was not biopsied. Histopathology confirmed MPNST in 2 dogs and schwannoma in 1 dog. Fluorescein-related adverse events were not observed. Both MPNST cases developed remote or metastatic disease within 4 months (1 euthanized); the schwannoma case was recurrence-free at 3 months. Clinical Relevance: Fluorescein sodium-guided resection of canine cervical PNSTs is feasible with widely available equipment and may aid intraoperative identification of tumor tissue in both primary and re-operative settings, suggesting a lower equipment barrier than commonly assumed. Because nonfluorescent tissue was not sampled, fluorescein should be an adjunct to, not a substitute for, surgical judgment.

Journal of the American Veterinary Medical Association
Nippon Veterinary and Life Science University (JP)
Good health and well-being
Veterinary Oncology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon